BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
246 hedge funds and large institutions have $3.74B invested in Blueprint Medicines in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 84 increasing their positions, 91 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
41% less capital invested
Capital invested by funds: $6.29B → $3.74B (-$2.55B)
47% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 64
Holders
246
Holding in Top 10
5
Calls
$11.6M
Puts
$7.29M
Top Buyers
| 1 | +$191M | |
| 2 | +$93.9M | |
| 3 | +$34.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$34.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$27.6M |
Top Sellers
| 1 | -$73M | |
| 2 | -$60.2M | |
| 3 | -$48.8M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$45M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$42.3M |